FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063297 [Registered on: 29/02/2024] Trial Registered Prospectively
Last Modified On: 20/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   CO2 Laser vs Traditional Scalpel for surgical management of oral precancerous lesions 
Scientific Title of Study   Comparative evaluation of CO2 Laser and traditional scalpel in the surgical management of oral potentially malignant disorder- A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vartik Shah 
Designation  Post Graduate Student 
Affiliation  Government Dental College & Hospital, Nagpur 
Address  Department 106, Oral and Maxillofacial Surgery, Government Dental College & Hospital, Nagpur

Nagpur
MAHARASHTRA
440003
India 
Phone  9930014736  
Fax    
Email  dr.vartik@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abhay Datarkar 
Designation  Dean and Professor 
Affiliation  Government Dental College & Hospital, Nagpur 
Address  Department 106, Oral and Maxillofacial Surgery, Government Dental College & Hospital, Nagpur

Nagpur
MAHARASHTRA
440003
India 
Phone  9930014736  
Fax    
Email  abhaydatarkar@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vartik Shah 
Designation  Post Graduate Student 
Affiliation  Government Dental College & Hospital, Nagpur 
Address  Department 106, Oral and Maxillofacial Surgery, Government Dental College & Hospital, Nagpur

Nagpur
MAHARASHTRA
440003
India 
Phone  9930014736  
Fax    
Email  dr.vartik@gmail.com  
 
Source of Monetary or Material Support  
Government Dental College & Hospital, Nagpur 
 
Primary Sponsor  
Name  Dr Vartik Shah 
Address  Department 106, Oral and Maxillofacial Surgery, Government Dental College and Hospital Nagpur 
Type of Sponsor  Other [Self Funded] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vartik Shah  Government Dental College and hospital Nagpur  Department 106, Oral and Maxillofacial Surgery
Nagpur
MAHARASHTRA 
09930014736

dr.vartik@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Government Dental College & Hospital, Nagpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K132||Leukoplakia and other disturbancesof oral epithelium, including tongue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Co2 Laser  Use of Co2 laser for surgical management of oral potentially malignant disorder under necessary anaesthesia- surgery lasting upto maximum of 2 hours. Follow up taken till 2 weeks post operatively 
Comparator Agent  Traditional Scalpel  Use of traditional scalpel for surgical management of oral potentially malignant disorder under necessary anaesthesia- surgery lasting upto maximum of 2 hours. Follow up taken till 2 weeks post operatively  
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1. All the patients reporting to department with oral potentially malignant disorders

2. Patients of age 15 years and above and below 75 years

3. Patients fit to undergo surgical excision under necessary anaesthesia

4. Patients with controlled blood sugar level

5. Patients with good general health status
 
 
ExclusionCriteria 
Details  1. Patients with systemic immunocompromised conditions

2. Patients who are pregnant/ lactating mothers

3. Patients on steroids or oral contraceptives

4. Patients not fit to undergo surgical excision under necessary anaesthesia

5. Patients not willing to be a part of the study
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment    
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Post-operative pain
2.Post operative swelling/edema
 
On the day of surgery, first and second week post operatively  
 
Secondary Outcome  
Outcome  TimePoints 
Ease of operability  On the day of surgery 
Intraoperative bleeding  On the day of surgery 
Post-operative scarring   First and second week post operatively  
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   11/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [dr.vartik@gmail.com].

  6. For how long will this data be available start date provided 13-02-2025 and end date provided 11-03-2026?
    Response (Others) - 

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Oral Potentially Malignant Diseases, abbreviated as OPMD, is a term used to describe a number of oral mucosal conditions that have a higher chance of developing cancer. Oral leukoplakia, erythroplakia, erythroleukoplakia, oral submucous fibrosis (OSF), palatal lesions in reverse smokers, and oral lichen planus are among the variety of OPMDs. Surgical removal of the lesion (cold-knife, laser excision and vaporization, cryosurgery, photodynamic therapy), medical treatment(topical or systemic), cessation of risk activities and surveillance has been the standard care of these lesions

CO2 laser was invented in 1964 by Kumar Patel. Since the 1970s, CO2 laser therapy has demonstrated to be a successful means of treating patients with a variety of oral lesions. When combined with diligent clinical follow-up, patient education to reduce risk factors, and reporting and biopsying of any suspicious lesions, laser surgery for oral premalignant disease has shown to be an efficient treatment option. 

CO2 laser is considered to be the ideal laser and is very useful in oral surgical procedures since the energy is maximally absorbed by water in oral tissues. Cellular vaporisation occurs due to photothermal effect which is the basis for tissue cutting by CO2 laser. The heat generated by the laser raises the temperature within the target tissues above 100 ° C, which results in the conversion of water into steam. As this causes instantaneous vaporisation of intracellular fluid, it is thought that it may prevent the release of chemical mediators of inflammation, and thereby reducing the acute inflammatory response. A virtually bloodless field is created as blood vessels with a lumen of less than 0.5 mm are sealed off with the laser

In comparison to scalpels, laser surgery has been found to have a number of benefits. These benefits include less post-operative pain, less scarring, and haemostasis. It also has the benefits of minimally affecting nearby tissue, delaying the immediate inflammatory response, and reducing myofibroblast activity, which reduces wound contraction and scarring. The reduction in collagen production in post-operative phase maintains soft tissue movement. It is also possible to leave the laser-treated region exposed to granulate without the requirement for skin grafting or wound dressing. It is also hypothesised that laser surgery causes less post-operative discomfort

  This study is planned in the department of oral and maxillofacial surgery to assess and compare ease of operability and healing outcomes on the day of surgery, first and second week post operatively following excision of OPMDs with CO2 laser when compared to excision done with a scalpel and evaluating on the basis of intraoperative time , intraoperative bleeding and post-operative pain, swelling and scarring


PRIMARY RESEARCH QUESTION:

 Whether CO2 Laser is a valuable tool and better alternative to traditional scalpel for surgical management of Oral Potentially Malignant Diseases

Primary Hypothesis- There is no statistically significant difference in intraoperative bleeding, ease of operability and post-operative pain, swelling and scarring between CO2 lasers and traditional scalpel when used for surgical management of Oral Potentially Malignant Diseases

Alternate Hypothesis-There is statistically significant difference in intraoperative bleeding, ease of operability and post-operative pain, swelling and scarring between CO2 lasers and traditional scalpel when used for surgical management of Oral Potentially Malignant Diseases

 
Close